ZVSA

ZyVersa Therapeutics

Delisted

ZVSA was delisted on the 16th of July, 2025.

7 hedge funds and large institutions have $43.9K invested in ZyVersa Therapeutics in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
-1
Holders Change %
-12.5%
% of All Funds
0.1%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
UBS Group
1
UBS Group
Switzerland
$17.8K +$15.2K +24,140 +577%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$13.6K +$13.6K +21,706 New
VF
3
Virtu Financial
New York
$11K -$4.85K -7,732 -31%
TRCT
4
Tower Research Capital (TRC)
New York
$1.36K -$835 -1,328 -38%
Bank of America
5
Bank of America
North Carolina
$70 +$1 +2 +2%
SS
6
SBI Securities
Japan
$31
Morgan Stanley
7
Morgan Stanley
New York
$1
Citigroup
8
Citigroup
New York
-$37.1K -35,035 Closed
Renaissance Technologies
9
Renaissance Technologies
New York
-$13.7K -12,961 Closed